Skip to main content

Table 2 Variations in the perceived efficacy of providing buprenorphine between DATA-waivered providers and non-waivered providers

From: Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants

Perceived efficacya

Waivered

Non-waivered

Mann–Whitney

Disagree

n (%)

Neither

n (%)

Agree

n (%)

Mdn

Disagree

n (%)

Neither

n (%)

Agree

n (%)

Mdn

r

U

Pb

Decreases risk of death from an opioid overdose

1 (1)

3 (3)

101 (96)

3

6 (8)

16 (20)

56 (72)

3

0.34

5095

 < 0.001

Decreases cravings for opioids

1 (1)

4 (4)

101 (95)

3

3 (4)

10 (13)

63 (83)

3

0.20

4528

0.01

Decreases rates of relapse

2 (2)

9 (8)

95 (90)

3

4 (5)

17 (24)

51 (71)

3

0.24

4534

 < 0.001

Works well in clients with co-occurring mental health disorders

2 (2)

9 (8)

96 (90)

3

3 (4)

23 (32)

47 (64)

3

0.30

4886

 < 0.001

Should be supplemented by mental health counseling

4 (4)

7 (7)

88 (89)

3

1 (1)

6 (8)

67 (91)

3

0.03

3594

0.69

Should be supplemented by participation in peer support groups

3 (3)

10 (9)

93 (88)

3

2 (3)

8 (11)

63 (86)

3

0.02

3923

0.79

Efficacy is improved by adding mental health counseling

2 (2)

8 (7)

96 (91)

3

0

6 (8)

70 (92)

3

0.03

3960

0.69

Appropriate for unstable patients

22 (21)

32 (31)

50 (48)

2

24 (35)

26 (38)

18 (27)

2

0.22

4398

0.004

  1. Mdn median
  2. aTotals vary due to missing values
  3. bBold values indicate significance at an alpha of 0.05